Glenmark gets approval to trial favipiravir for Covid-19 in India
The trial assesses the drug in Covid-19 patients with mild to moderate infection. Credit: Gerd Altmann from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more